Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (221-230 of 311) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|February 7, 2012
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCTR Tizon, N Frey, D F Heitjan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioningRan Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid LeukemiaHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical TrialRan Reshef, Alex Ganetsky, Edward P Acosta, et al.
Transplantation Proceedings|February 1, 1996
Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donorsC F Bryan, G E Tegtmeier, A Polito, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapyH C Moore, R Mick, L J Solin, et al.
Pageof 32

Showing results (221-230 of 311) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|February 7, 2012
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCTR Tizon, N Frey, D F Heitjan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioningRan Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid LeukemiaHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical TrialRan Reshef, Alex Ganetsky, Edward P Acosta, et al.
Transplantation Proceedings|February 1, 1996
Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donorsC F Bryan, G E Tegtmeier, A Polito, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapyH C Moore, R Mick, L J Solin, et al.
Pageof 32